U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H24N2O3S.ClH
Molecular Weight 408.942
Optical Activity ( + )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEACETYLDILTIAZEM HYDROCHLORIDE

SMILES

Cl.COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2O

InChI

InChIKey=XNQWAVFYFJXSHD-VOMIJIAVSA-N
InChI=1S/C20H24N2O3S.ClH/c1-21(2)12-13-22-16-6-4-5-7-17(16)26-19(18(23)20(22)24)14-8-10-15(25-3)11-9-14;/h4-11,18-19,23H,12-13H2,1-3H3;1H/t18-,19+;/m1./s1

HIDE SMILES / InChI

Molecular Formula C20H24N2O3S
Molecular Weight 372.481
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
The influence of diltiazem versus cimetidine on propranolol metabolism.
1992 Dec
Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation.
1996 Apr
Increased urinary cortisol and androgen metabolites in a young female with hypertension: partial glucocorticoid resistance syndrome.
2000
Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
2000 Jun
Effects of diltiazem on down-regulation of lymphocyte beta-adrenoceptors in patients with chronic congestive heart failure.
2000 Oct
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.
2000 Sep
Slowing the progression of renal disease in diabetic patients.
2001 Apr
Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
2002
The role of calcium antagonists in chronic kidney disease.
2004 Mar
Patents

Patents

Substance Class Chemical
Created
by admin
on Tue Apr 01 17:48:12 GMT 2025
Edited
by admin
on Tue Apr 01 17:48:12 GMT 2025
Record UNII
ZQ8A4H7BT3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(2S-CIS)-5-(2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE MONOHYDROCHLORIDE
Preferred Name English
DEACETYLDILTIAZEM HYDROCHLORIDE
Common Name English
DESACETYLDILTIAZEM HYDROCHLORIDE
Common Name English
1,5-BENZOTHIAZEPIN-4(5H)-ONE, 5-(2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-, MONOHYDROCHLORIDE, (2S,3S)-
Systematic Name English
1,5-BENZOTHIAZEPIN-4(5H)-ONE, 5-(2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-, HYDROCHLORIDE (1:1), (2S,3S)-
Systematic Name English
Code System Code Type Description
FDA UNII
ZQ8A4H7BT3
Created by admin on Tue Apr 01 17:48:12 GMT 2025 , Edited by admin on Tue Apr 01 17:48:12 GMT 2025
PRIMARY
PUBCHEM
12449428
Created by admin on Tue Apr 01 17:48:12 GMT 2025 , Edited by admin on Tue Apr 01 17:48:12 GMT 2025
PRIMARY
CAS
75472-91-2
Created by admin on Tue Apr 01 17:48:12 GMT 2025 , Edited by admin on Tue Apr 01 17:48:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
278-217-7
Created by admin on Tue Apr 01 17:48:12 GMT 2025 , Edited by admin on Tue Apr 01 17:48:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID10226411
Created by admin on Tue Apr 01 17:48:12 GMT 2025 , Edited by admin on Tue Apr 01 17:48:12 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE